01229nam a2200193   4500001000700000010001500007100004100022101000800063200016700071210008300238215001800321225003100339330051700370606004100887606001600928606002200944606000900966710006000975384311  a9291681377  a20070529d2003       y0pory50      ba  aeng  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA  aLuxembourgcOffice for Official Publications of the European Communitiesd2003  a122 p.d21 cm  aEMCDDA Risk Assessmentsv5  aForeword. Abbreviations. Introduction. Chapter 1: Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Chapter 2: Council decision. Chapter 3: Europol-EMCDDA progress report on PMMA and PMA. Chapter 4: Review of the pharmacotoxicological data on PMMA. Chapter 5: Sociological and criminological evidence on the risks of PMMA. Chapter 6: Public health risks of PMMA - epidemiological evidence. References. Participants in the risk assessment process. Further reading.  aPREVENÇÃO DA TOXICODEPENDÊNCIA  aRELATÓRIO  aDROGA SINTÉTICA  aOEDT  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION